What are the management of nephrotic syndrome?

Nephrotic Syndrome usually presents with the classic triad of oedema, proteinuria and hypoalbuminaemia.

Oedema can be non-dependant eg periorbital. Consider other causes of generalised oedema eg liver disease, congestive cardiac failure and protein losing enteropathy.  

Assessment of severity and complications:

  • Intravascular volume depletion (although children are invariably oedematous, they can be concurrently intravascular volume deplete):                                     
    • dizziness, abdominal cramps 
    • peripheral hypoperfusion (cold hands or feet, mottling, capillary refill time >2 seconds)
    • tachycardia, reduced urine output, hypotension (late sign) 
  • Severe or symptomatic oedema:
    • discomfort (genital, abdominal), gross scrotal / vulval oedema
    • gross limb oedema with potential for skin breakdown / cellulitis
    • increased work of breathing from pleural effusion 
    • ascites
  • Infection (increased risk in nephrotic state):                                      
    • cellulitis
    • spontaneous bacterial peritonitis – abdominal pain, fever, nausea/vomiting, rebound tenderness 
  • Thrombosis (increased risk in nephrotic state)

Features suggesting diagnosis other than INS 

  • Age <18 months or >12 years 
  • Systemic symptoms of fever, rash, joint pains (SLE, HSP)
  • Persistent hypertension (can have mild hypertension first 1–2 days) 
  • Features of nephritic syndrome (macroscopic haematuria, hypertension and renal impairment)

Management

Investigations

The diagnosis of nephrotic syndrome includes: 

  • Heavy proteinuria (dipstick 3–4+ or urine protein/creatinine ratio >0.2 g/mmol = >200 mg/mmol)
  • Hypoalbuminaemia (<25 g/L)

Urine

  • Dipstick: proteinuria 3–4+
  • Microscopy: quantify any haematuria – INS may have microscopic haematuria
  • Consider:
    • spot protein : creatinine ratio >0.2 g/mmol  
    • sodium <10 mmol/L (consider if concerns about intravascular volume depletion)

Blood

  • FBE
  • UEC: may have mild elevation of serum creatinine with mod-severe volume depletion. If creatinine very high, consider nephritic syndrome
  • LFT including albumin

Treatment (for INS)

1. Admit to hospital on first presentation

2. If the child is profoundly ill or appears to have sepsis treat accordingly (see Sepsis)

3. Manage oedema

  • No added salt diet
  • Daily weights, daily urine dipstick
  • Strict fluid balance with close attention to volume status

    Albumin and Furosemide 
    Indications include: intravascular volume depletion, severe or symptomatic oedema (see assessment section above)
    Monitor for hypertension and pulmonary oedema

    Albumin: 20% Albumin 5 mL/kg (1 g/kg) over 4 hours IV

    Furosemide: 1 mg/kg max 40 mg over 20 minutes IV

  • Give mid albumin infusion provided adequate peripheral perfusion
  • A second dose may be required at the end of albumin infusion if severe or symptomatic oedema (discuss with nephrology)   


4.Steroid therapy

  • Prednisolone: to induce remission, followed by a slow wean to reduce risk of relapse
    • 60 mg/m2/day (max 60 mg) for 4 weeks
    • then 40 mg/m2/day (max 40 mg) on alternate days for 4 weeks
    • then 20 mg/m2/day on alternate days for 10 days
    • then 10 mg/m2/day on alternate days for 10 days
    • then 5 mg/m2/day on alternate days for 10 days
    • then cease
      Body Surface Area (m2) calculator
      When calculating maximum doses use pre-morbid weight if known
  • Defer live vaccines whilst on high dose steroids - see Australian Immunisation Handbook 

5. Prophylaxis against complications 

  • Infection
    • Routine prophylaxis is not indicated unless there is risk of pneumococcal infection (eg gross or symptomatic oedema, unimmunised) 
    • If indicated, manage with oral penicillin V (phenoxymethylpenicillin) 125 mg/dose 12 hourly if under 5 years, or 250 mg/dose 12 hourly if over 5 years. Cease after oedema subsides
  • Gastritis
    • Routine use of acid suppressing therapies is not indicated unless there are upper gastrointestinal symptoms while on steroid therapy

Treatment of relapses

A relapse is defined as proteinuria 3+ or 4+ for 3 consecutive days, and should prompt re-introduction of full dose prednisolone:  

  • Prednisolone 60 mg/m2/day (max 60 mg) until urine protein is 0, trace or + for 3 consecutive days
  • Then weaning regimen:  
    • 40 mg/m2/day on alternate days for 2 weeks
    • 20 mg/m2/day on alternate days for 2 weeks
    • 15 mg/m2/day on alternate days for 2 weeks
    • 10 mg/m2/day on alternate days for 2 weeks
    • 5 mg/m2/day on alternate days for 2 weeks
      Body Surface Area (m2) calculator
      When calculating maximum doses use pre-morbid weight if known

The total time of weaning regimen can be shortened if the child relapses infrequently (2–3 relapses in any 12-month period) and responds to treatment quickly

What are the main goals of treatment management for nephrotic syndrome?

OBJECTIVES OF SYMPTOMATIC TREATMENT: The goal is to maintain quality of life, prevent immediate complications (thromboembolic events, infection, drug reactions), prevent late complications related to atherosclerosis, and limit the progression of the chronic renal failure.

What is the first line treatment for nephrotic syndrome?

Corticosteroids are currently used as first-line treatment. A 16 weeks full-dose steroid course (1 mg/kg/day) usually induces remission in 75% MCNS in adults.

What is the expected management for the child with nephrotic syndrome?

Children diagnosed with nephrotic syndrome for the first time are normally prescribed at least a 4-week course of the steroid medicine prednisolone, followed by a smaller dose every other day for 4 more weeks. This stops protein leaking from your child's kidneys into their urine.

What are the prevention of nephrotic syndrome?

You can't prevent some causes of nephrotic syndrome. But you can take action to avoid damage to your glomeruli: Manage high blood pressure and diabetes, if you have them. Be sure to get vaccines for common infections, especially if you work around people who have hepatitis or other diseases.